当前位置: X-MOL 学术Expert Rev. Anti Infect. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications
Expert Review of Anti-infective Therapy ( IF 5.7 ) Pub Date : 2021-07-26 , DOI: 10.1080/14787210.2021.1935238
Zikria Saleem 1 , Brian Godman 2, 3, 4 , Faiza Azhar 5 , Aubrey C Kalungia 6 , Joseph Fadare 7 , Sylvia Opanga 8 , Vanda Markovic-Pekovic 9 , Iris Hoxha 10 , Amna Saeed 1 , Manal Al-Gethamy 11 , Abdul Haseeb 12 , Muhammad Salman 1 , Ayaz Ali Khan 1 , Muhammad Umer Nadeem 5 , Inaam Ur Rehman 5 , Muhammad Usman Qamar 13 , Afreenish Amir 14 , Aamer Ikram 14 , Muhammad Azmi Hassali 4
Affiliation  

ABSTRACT

Introduction

The emergence of antimicrobial resistance (AMR) is a threat to public health. In 2015, the World Health Organization (WHO) introduced a global action plan to tackle AMR in the World Health Assembly. Pakistan’s national action plan (NAP) for AMR was released in May 2017 by the Ministry of National Health Services. Based on the NAP, strategies have been initiated on a national and provincial scale in Pakistan.

Areas covered

This narrative review of the five components of the Pakistan NAP has been undertaken to discuss some of the challenges in implementation of the NAP for AMR in Pakistan including different opinions and views of key stakeholders, combined with suggestions on potential ways to reduce the burden of the AMR.

Expert opinion

Going forward, healthcare authorities should focus on screening and monitoring of all the objectives of the NAP by establishing proper policies as well as promoting antimicrobial stewardship interventions and Infection prevention and control (IPC) practices. Overall, the comprehensive strengthening of the healthcare system is required to adequately implement the NAP, tackle continued inappropriate antimicrobial use and high AMR rates in Pakistan.



中文翻译:

巴基斯坦抗微生物药物耐药性(AMR)国家行动计划的进展:叙述性审查及其影响

摘要

介绍

抗菌素耐药性 (AMR) 的出现对公众健康构成威胁。2015 年,世界卫生组织 (WHO) 在世界卫生大会上提出了一项应对 AMR 的全球行动计划。巴基斯坦国家卫生服务部于 2017 年 5 月发布了针对 AMR 的国家行动计划 (NAP)。在国家行动计划的基础上,巴基斯坦已经在国家和省级范围内启动了战略。

涵盖的领域

对巴基斯坦国家行动计划的五个组成部分进行了叙述性审查,以讨论在巴基斯坦实施抗菌素耐药性国家行动计划的一些挑战,包括主要利益攸关方的不同意见和观点,并结合关于减轻药物耐药性负担的潜在方法的建议。 AMR。

专家意见

展望未来,医疗保健当局应通过制定适当的政策以及促进抗菌药物管理干预和感染预防和控制 (IPC) 实践,专注于筛查和监测 NAP 的所有目标。总体而言,需要全面加强医疗保健系统,以充分实施 NAP,解决巴基斯坦持续不适当的抗菌药物使用和高抗菌素耐药率问题。

更新日期:2021-07-26
down
wechat
bug